Health Catalyst annual debt-to-equity ratio
2019
2020
2021
2022
2023
2024
2025
Health Catalyst Debt-to-Equity Ratio Growth & History (HCAT)
Health Catalyst's debt-to-equity ratio was 0.70 for fiscal 2025.
View full Health Catalyst company overviewHealth Catalyst annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.70 | −0.40 | −36.75% |
| 2024 | 2024-12-31 | 1.10 | 0.42 | +62.27% |
| 2023 | 2023-12-31 | 0.68 | 0.10 | +16.34% |
| 2022 | 2022-12-31 | 0.58 | 0.19 | +48.88% |
| 2021 | 2021-12-31 | 0.39 | −0.32 | −44.59% |
| 2020 | 2020-12-31 | 0.71 | 0.44 | +169.49% |
| 2019 | 2019-12-31 | 0.26 | — | — |
Health Catalyst quarterly debt-to-equity ratio
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.69 | 1.19 | +239.09% |
| Q1 2026 | 2026-03-31 | 1.23 | 0.17 | +15.64% |
| Q4 2025 | 2025-12-31 | 0.70 | −0.40 | −36.75% |
| Q3 2025 | 2025-09-30 | 0.52 | −0.51 | −49.47% |
| Q2 2025 | 2025-06-30 | 0.50 | 0.44 | +793.03% |
| Q1 2025 | 2025-03-31 | 1.07 | 0.37 | +53.27% |
| Q4 2024 | 2024-12-31 | 1.10 | 0.42 | +62.27% |
| Q3 2024 | 2024-09-30 | 1.03 | 0.37 | +57.41% |
| Q2 2024 | 2024-06-30 | 0.06 | −0.58 | −91.30% |
| Q1 2024 | 2024-03-31 | 0.70 | 0.09 | +13.94% |
| Q4 2023 | 2023-12-31 | 0.68 | 0.10 | +16.34% |
| Q3 2023 | 2023-09-30 | 0.65 | 0.09 | +15.56% |
| Q2 2023 | 2023-06-30 | 0.64 | 0.11 | +20.85% |
| Q1 2023 | 2023-03-31 | 0.61 | 0.09 | +18.35% |
| Q4 2022 | 2022-12-31 | 0.58 | 0.19 | +48.88% |
| Q3 2022 | 2022-09-30 | 0.56 | 0.52 | +1177.83% |
| Q2 2022 | 2022-06-30 | 0.53 | 0.44 | +488.45% |
| Q1 2022 | 2022-03-31 | 0.52 | 0.42 | +443.93% |
| Q4 2021 | 2021-12-31 | 0.39 | −0.32 | −44.59% |
| Q3 2021 | 2021-09-30 | 0.04 | −0.60 | −93.14% |
| Q2 2021 | 2021-06-30 | 0.09 | −0.68 | −88.26% |
| Q1 2021 | 2021-03-31 | 0.09 | −0.16 | −62.83% |
| Q4 2020 | 2020-12-31 | 0.71 | 0.44 | +169.49% |
| Q3 2020 | 2020-09-30 | 0.64 | 0.39 | +150.21% |
| Q2 2020 | 2020-06-30 | 0.77 | — | — |
| Q1 2020 | 2020-03-31 | 0.26 | — | — |
| Q4 2019 | 2019-12-31 | 0.26 | — | — |
| Q3 2019 | 2019-09-30 | 0.26 | — | — |
Health Catalyst debt-to-equity ratio trends
Over the last five fiscal years, Health Catalyst's debt-to-equity ratio decreased from 0.71 to 0.70, a change of −0.01. The latest reported quarter, Q2 2026, shows 1.69.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Health Catalyst source filings ↗